Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors.
Price History & Performance
|Historical stock prices|
|Current Share Price||US$9.12|
|52 Week High||US$8.46|
|52 Week Low||US$99.89|
|1 Month Change||-4.10%|
|3 Month Change||-66.88%|
|1 Year Change||-86.34%|
|3 Year Change||6.42%|
|5 Year Change||60.00%|
|Change since IPO||-99.95%|
Recent News & Updates
Ontrak: Why You Should Buy The Dip
Ontrak has a unique value proposition, which differentiates itself from other HealthTech companies. Shares are down 85% YTD, presenting a compelling valuation. Investors with a longer-term time horizon could see a potential triple digit upside.
|OTRK||US Healthcare||US Market|
Return vs Industry: OTRK underperformed the US Healthcare industry which returned 30.1% over the past year.
Return vs Market: OTRK underperformed the US Market which returned 33.4% over the past year.
Stable Share Price: OTRK is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.
Volatility Over Time: OTRK's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
Ontrak, Inc. operates as an artificial intelligence powered, virtualized outpatient healthcare treatment company that provides in-person or telehealth intervention services to health plans and other third-party payors. Its Ontrak PRE (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends care pathways that people are willing to follow, and engages people who aren’t getting the care they need. The company’s technology-enabled, OnTrak, program is designed to treat health plan members with unaddressed behavioral health conditions that cause or exacerbate chronic medical diseases, such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure.
Ontrak Fundamentals Summary
|OTRK fundamental statistics|
Is OTRK overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|OTRK income statement (TTM)|
|Cost of Revenue||US$47.76m|
Last Reported Earnings
Jun 30, 2021
Next Earnings Date
Nov 04, 2021
|Earnings per share (EPS)||-1.28|
|Net Profit Margin||-22.65%|
How did OTRK perform over the long term?See historical performance and comparison
Is Ontrak undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: OTRK ($9.12) is trading below our estimate of fair value ($18.35)
Significantly Below Fair Value: OTRK is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: OTRK is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.
PE vs Market: OTRK is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate OTRK's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: OTRK is good value based on its PB Ratio (3x) compared to the US Healthcare industry average (3.1x).
How is Ontrak forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OTRK is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OTRK is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OTRK is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: OTRK's revenue (3.6% per year) is forecast to grow slower than the US market (9.9% per year).
High Growth Revenue: OTRK's revenue (3.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if OTRK's Return on Equity is forecast to be high in 3 years time
How has Ontrak performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: OTRK is currently unprofitable.
Growing Profit Margin: OTRK is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: OTRK is unprofitable, and losses have increased over the past 5 years at a rate of 12.6% per year.
Accelerating Growth: Unable to compare OTRK's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OTRK is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (32.2%).
Return on Equity
High ROE: OTRK has a negative Return on Equity (-30.68%), as it is currently unprofitable.
How is Ontrak's financial position?
Financial Position Analysis
Short Term Liabilities: OTRK's short term assets ($115.2M) exceed its short term liabilities ($26.7M).
Long Term Liabilities: OTRK's short term assets ($115.2M) exceed its long term liabilities ($47.6M).
Debt to Equity History and Analysis
Debt Level: OTRK's debt to equity ratio (79.3%) is considered high.
Reducing Debt: OTRK had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: OTRK has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if OTRK has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
What is Ontrak current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate OTRK's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate OTRK's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if OTRK's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if OTRK's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of OTRK's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jonathan Mayhew (57 yo)
Mr. Jonathan Edwin Mayhew serves as the Chief Executive Officer at Ontrak, Inc. since April 12, 2021. He served as Executive Vice President & Chief Transformation Officer at CVS Health Corporation since Fe...
Experienced Management: OTRK's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Experienced Board: OTRK's board of directors are considered experienced (3 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: OTRK insiders have only sold shares in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 10.1%.
Ontrak, Inc.'s employee growth, exchange listings and data sources
- Name: Ontrak, Inc.
- Ticker: OTRK
- Exchange: NasdaqGM
- Founded: 2003
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$174.627m
- Shares outstanding: 19.15m
- Website: https://www.ontrak-inc.com
Number of Employees
- Ontrak, Inc.
- 2120 Colorado Avenue
- Suite 230
- Santa Monica
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/10/26 22:37|
|End of Day Share Price||2021/10/26 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.